Science
/AAAS
Skip to content
AAAS.ORG
Feedback
Help
Librarians
Alerts
Access Rights
Sign In
Science Magazine
Daily News
Science Signaling
Science Translational Medicine
SAGE KE
Science Careers
All HighWire Journals
Advanced
News
Science Journals
Careers
Communities
Multimedia
Topics
Subscribe
Help
Meetings & Events
About
Science
Careers
Contact
My Science Career
My Account
My Résumés
My Cover Letters
My Applications
My Jobs
My Searches
My Job Alerts
Find a Job
Job Search
Browse All Jobs
By Employer
Biotechnology Jobs
Faculty Jobs
Postdoctoral Jobs
For Employers
Search Résumés
Post a Job
Meetings & Events
Contact
Career Magazine
Issues & Perspectives
Career Advice
The Job Market
Career Profiles
Life & Career
Diversity Issues
CTSciNet
Blogs
Grants & Funding
Funding Home
GrantsNet Account
Search GrantsNet
Funding Directory
Funding News
Post a Grant
Tools & Tips
How-To Series
Outreach
Graduate Programs
Multimedia
Facebook
Community
MySciNet
CTSciNet
Forum
Science
Home
>
Science
Careers
>
Funding
>
Search GrantsNet
>
Search Results
>
Programs
Grants & Funding
GrantsNet Tools:
Saved Searches
|
Saved Grants
|
GrantsNet Express Alerts
Alzheimer's Drug Discovery Foundation
Published Date: January 13, 2010
Program Information
Program Name:
ADDF Biotechnology Development Program
Program URL:
http://www.alzdiscovery.org/wp-content/uploads/2009/08/2009-addf-general-rfp1.pdf
Type of Scientists Funded:
Advanced PhD Postdoc, Junior Faculty, Senior Scientist/Faculty
Program Description:
The Alzheimer's Drug Discovery Foundation (ADDF) funds drug discovery research programs from domestic and international investigators in academia and biotechnology companies. In addition, ADDF initiates, sponsors, and co-sponsors conferences to stimulate new ideas and approaches in areas of interest to the foundation, bringing together physicians, scientists, and policy makers worldwide.
The ADDF Biotechnology Development Program supports qualified scientific projects in existing, private, early-stage biotechnology companies. ADDF will provide support for qualified projects in more advanced companies if a clear need for nonprofit funding to support the project can be demonstrated and justified.
ADDF supports the development of biomarkers, such as (1) advanced brain imaging technologies, (2) cerebral spinal fluid tests and (3) blood tests for the early detection of mild cognitive impairment, Alzheimer's disease and related dementias. ADDF also supports clinical research projects to improve early detection of cognitive impairment through population-based approaches that can impact large numbers of individuals at risk.
Grant applications are usually solicited by private invitation. Unsolicited proposals are also accepted, but inquiries with ADDF staff are encouraged to determine the foundation's interest prior to application. ADDF provides support for 1 year of research with potential for future follow-on funding. The foundation seeks successful long-term partnerships with investigators and research organizations.
Public Contact Information
Name:
Diana Shineman Ph.D.
Title:
Assistant Director for Scientific Affairs
Organization:
Alzheimer's Drug Discovery Foundation
Department:
Address:
1414 Avenue of the Americas
Suite 1502
New York, New York 10019
Phone:
212-901-8003
Fax:
E-mail:
dshineman@alzdiscovery.org
Country:
United States
Program Award Term and Application Process
Award Term Fixed or Variable?
Fixed
If fixed, enter total term?
1 Year
Award Renewable?
Yes
Renewable term fixed or variable?
Fixed
If fixed, enter total term?
1 Year
Does an individual or institution apply to the program?
Individual
Is there an application deadline?
Yes
Application deadline(s):
04/01/2010,
07/01/2010,
10/01/2010
Deadline Comments
Grant applications are reviewed quarterly and are usually solicited by private invitation. Unsolicited proposals are also accepted, but inquiries with ADDF staff are encouraged to determine the Foundation's interest prior to application. ADDF provides support for 1 year of research with potential for future follow-on funding. We seek successful long-term partnerships with investigators and research organizations.
Full application guidelines and further information can be found on our website. All applicants are required to complete an electronic "Letter of Intent" (LOI) available on our website. LOI should be submitted at least 2 weeks before the application deadline. After review of the LOI, we may invite a full application via email with a link to the electronic application form. ADDF will attempt to make a determination of interest within 90 days of receipt of the application.
Program FUNDS
Stipend Information:
Annual stipend type:
Percentage
Percent:
0-100 %
Research Allowance Information:
Annual research allowance type:
Variable
Minimum:
$ 0
Maximum:
$ 300000
Indirect Costs (Institutional Funds) Information:
Indirect costs type:
Not Applicable
Other Costs Information:
Other Costs type:
Not Applicable
Program Eligibility Requirements
Research Areas:
Biochemistry, Biology, Cell Biology, Clinical Research, Disease-Specific Research: Alzheimer's Disease, Molecular Biology, Neuroscience, Pharmacology, Other (specify): Biotechnology
Application by invitation or nomination only?
No
Are awards limited to specific groups?
None provided
Must applicants be U.S. citizens and/or permanent residents?
No
U.S. geographic limits?
No
International geographic limits?
Institutional limits?
No
Non-research activity allowed for postdoctoral and junior faculty awards?
If yes, specify at least one of the following: percentage time and activities allowed
Program competition information
Number of Applicants in Most Recent Competition Year:
200
Number of Awards in Most Recent Competition Year:
30
Institutional Award Rates
Category
# Applicants
# Awards
Institutional Awards
Awardee's subsequent careers/accomplishments tracked after end of term?
Total dollars awarded in the most recent competition year
3800000